LB PHARMACEUTICALS INC LBRX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2025-09-11
LB PHARMACEUTICALS INC statistics & valuation
Market cap$915.4M
P / B3.0×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 |
|---|---|---|
| Return on assets | -8.1% | -188.2% |
| Return on equity | -8.4% | 66.7% |
| Current ratio | 41.44 | 3.56 |
Source: SEC EDGAR filings · CIK 0001691082 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.